Full Breakdown
Major Medical Institutions Halt Gender Treatments for Minors Amid Legal and Ethical Concerns
2/20/2026, 10:33:46 PM
Langone Medical Center's Policy Shift
Langone Medical Center in New York City has announced it will cease providing surgeries and hormone treatments for minors experiencing gender dysphoria. This decision marks a significant shift in the medical community, which has previously maintained that such procedures were rare and only necessary in extreme cases. The center will continue to offer mental health services for gender dysphoria but will no longer provide hormone therapies, including puberty blockers. This change has been influenced by recent legal developments, including a court ruling in New York that awarded $2 million to a detransitioner who underwent breast removal as a child, raising concerns about potential legal liabilities for medical providers.
Texas Lawsuit Against Gender Treatment Provider
In Texas, Attorney General Ken Paxton has filed a lawsuit against Dr. Jason Jarin of the Children's Health System of Texas, alleging that he unlawfully provided minors with puberty blockers and cross-sex hormones, violating state law. The lawsuit claims that Dr. Jarin engaged in medical fraud and defrauded state insurance programs. Texas passed Senate Bill 14 in June 2023, which prohibits sex-rejecting interventions for minors, yet Dr. Jarin allegedly continued these practices after the law took effect. The lawsuit contends that Dr. Jarin and his colleagues created a "wean protocol" to circumvent the law, allowing continued hormone treatments under the guise of medical necessity.
Implications of Legislative Changes
The legal actions in Texas and the policy changes at Langone Medical Center reflect a growing backlash against gender-affirming treatments for minors. Critics argue that these procedures can lead to irreversible consequences and that the medical community has not provided sufficient evidence to support their efficacy in improving mental health outcomes for transgender youth. The Texas lawsuit specifically highlights concerns about the ethical implications of administering treatments that are not FDA-approved for gender dysphoria, emphasizing the potential for long-term health issues, including sterility.
Criticism & Opposition
Opponents of gender-affirming care argue that the medical establishment has failed to adequately protect children from potentially harmful procedures. They assert that the narrative surrounding the necessity of these treatments is based on flawed logic and emotional appeals rather than solid medical evidence. Critics also point to the lack of documented improvements in mental health outcomes for minors undergoing such treatments, questioning the validity of claims that these interventions are essential for preventing suicide among transgender youth.
Official Statements & Responses
Children's Health System of Texas has stated that it prioritizes the health and well-being of its patients and complies with all applicable laws. However, due to ongoing legal proceedings, the institution has refrained from providing further comments on the allegations. The broader medical community remains divided, with some advocating for a reevaluation of gender-affirming treatments for minors in light of emerging legal and ethical concerns.
What's Next
As legal challenges and policy changes continue to unfold, the future of gender-affirming treatments for minors remains uncertain. The outcomes of lawsuits like the one in Texas could set significant precedents for how medical institutions approach gender dysphoria in children, potentially leading to more stringent regulations and a reevaluation of treatment protocols across the United States.
